Search Results

BNH NASDAQ DM Ex US Industrials Ind - Fundamental Analysis

BEARISH
Sign in to save Save this symbol to a watchlist or track a position.
BNH Stock | Fundamental Analysis & Investment Insights
NYSE N/A N/A
Current Price Live
$16.0
52W High
$17.36
52W Low
$14.5
Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
65%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 1/9, indicating severe deterioration in fundamental performance. The absence of an Altman Z-Score and all key valuation, profitability, and financial health metrics prevents a comprehensive safety assessment, but the lack of data itself signals transparency or reporting deficiencies. Despite modest short-to-medium-term price appreciation (1Y: +2.6%, 3Y: +7.0%), recent underperformance and missing technical averages suggest weakening momentum. With no dividend, no analyst coverage, and weak insider sentiment at 40/100, the investment case lacks both fundamental and qualitative support.

Key Strengths

Recent 3-year price performance (+7.0%) outpaces the 5-year trend, suggesting potential stabilization or recovery.
Current price ($16.00) is below 52-week high ($17.36), offering possible entry point if fundamentals improve.
Insider sentiment, while not strong, is neutral-to-mildly positive at 40/100, not indicating aggressive selling.
No dividend payout risk due to absence of dividend program.
Low current price relative to market data gaps may present speculative opportunity if transparency improves.

Key Risks

Piotroski F-Score of 1/9 indicates critical weakness in earnings, leverage, liquidity, and operating efficiency.
Missing Altman Z-Score and all financial ratios (ROE, ROA, Debt/Equity, etc.) raise red flags about data availability or financial distress.
No valuation metrics available (P/E, P/B, EV/EBITDA), making traditional and comparative valuation impossible.
Zero analyst coverage and target price data indicate lack of institutional interest or confidence.
Technical trend score of 0/100 confirms strong bearish momentum in price action.

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
22
Weak
Value
20
Future
30
Past
45
Health
10
Dividend
5
AI Verdict
High-risk, low-confidence investment with insufficient data to support a buy rating.
Key drivers: Critically low Piotroski F-Score, Missing financial and valuation data, Bearish technical trend, No analyst coverage, Lack of dividend or growth metrics
Confidence
60%
Value
20/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • All valuation metrics (P/E, PEG, Price/Book, EV/EBITDA) are unavailable
  • Graham Number is $None, preventing defensive value assessment
Future
30/100

Ref Growth rates

Positives
  • 3-year price change of +7.0% suggests possible future stabilization
Watchpoints
  • No revenue or earnings growth data (YoY or Q/Q)
  • No forward P/E or analyst growth estimates
Past
45/100

Ref Historical trends

Positives
  • 1-year return of +2.6% and 3-year return of +7.0% show some historical resilience
  • 52-week low of $14.50 provides recent support level
Watchpoints
  • 5-year change of -11.4% indicates long-term underperformance
  • Recent 1-month (-0.3%) and 1-week (-0.7%) declines show weakening momentum
Health
10/100

Ref Altman Z-Score, Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 1/9 indicates severe financial deterioration
  • Altman Z-Score is missing, preventing distress risk assessment
  • All financial health metrics (Debt/Equity, Current Ratio, ROE, ROA) are unavailable
Dividend
5/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend Strength is 0/100
  • No dividend yield, rate, or payout ratio data available
  • No history of dividend payments evident

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$16.0

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BNH and closest competitors.

Updated 2026-01-23
Company 5Y 3Y 1Y 6M 1M 1W
BNH
NASDAQ DM Ex US Industrials Ind
Primary
 -11.4% +7.0% +2.6% +2.9% -0.3% -0.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Past News Coverage

Recent headlines mentioning BNH from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Intelligence Terminal AI Assistant Trading Challenge Analysis Market News Pricing
Sign In Get Started
Home
Terminal
AI
Markets
Profile